GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Orphazyme AS (CHIX:ORPHAc) » Definitions » Dividend Yield %

Orphazyme AS (CHIX:ORPHAC) Dividend Yield % : 0.00% (As of Jun. 23, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Orphazyme AS Dividend Yield %?

As of today (2024-06-23), the Trailing Annual Dividend Yield of Orphazyme AS is 0.00%.

The historical rank and industry rank for Orphazyme AS's Dividend Yield % or its related term are showing as below:

CHIX:ORPHAc's Dividend Yield % is not ranked *
in the Biotechnology industry.
Industry Median: 1.61
* Ranked among companies with meaningful Dividend Yield % only.

Orphazyme AS's Dividend Payout Ratio for the three months ended in Jun. 2022 was 0.00.

As of today (2024-06-23), the Forward Dividend Yield % of Orphazyme AS is 0.00%.

Orphazyme AS's Dividends per Share for the three months ended in Jun. 2022 was kr0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Orphazyme AS Dividend Yield % Historical Data

The historical data trend for Orphazyme AS's Dividend Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orphazyme AS Dividend Yield % Chart

Orphazyme AS Annual Data
Trend Jun14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Dividend Yield %
Get a 7-Day Free Trial - - - - -

Orphazyme AS Quarterly Data
Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22
Dividend Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Orphazyme AS's Dividend Yield %

For the Biotechnology subindustry, Orphazyme AS's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Orphazyme AS's Dividend Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Orphazyme AS's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Orphazyme AS's Dividend Yield % falls into.



Orphazyme AS Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.


Orphazyme AS  (CHIX:ORPHAc) Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Orphazyme AS Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Orphazyme AS's Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Orphazyme AS (CHIX:ORPHAC) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Ole Maaloes Vej 3, Copenhagen, DNK, DK-2200
Orphazyme AS is a late-stage biopharmaceutical company engaged in the development and commercialization of novel therapeutics for the treatment of neurodegenerative rare diseases. The company's lead candidate, Arimoclomol, is in development for severe orphan diseases: Niemann-Pick disease Type C (NPC), Amyotrophic Lateral Sclerosis (ALS), and Inclusion Body Myositis (IBM).

Orphazyme AS (CHIX:ORPHAC) Headlines

No Headlines